SCHEMBL31411394

SCHEMBL31411394

COc1cc(F)c(Br)c(C=O)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.44
PRKDC P78527 1/20 0.43
ALDH1A1 P00352 9/20 0.42
TRIM24 O15164 1/20 0.41
TYR P14679 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
CYP1A2 P05177 3/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
KDM4E B2RXH2 2/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP2C19 P33261 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.36
CYP2A6 P11509 1/20 0.35
LMNA P02545 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6828189 0.86 ERN1 (0.52) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL23850354 0.81 ERN1 (0.47) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL1552502 0.80 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP1A1CYP1B1TAAR1
SCHEMBL28607913 0.79 PRKDC (0.48) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL6828147 0.79 ERN1 (0.46) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL120483 0.79 ALDH1A1 (0.56) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL6829006 0.78 ERN1 (0.44) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL29048895 0.78 ERN1 (0.58) ERN1PRKDCALDH1A1TRIM24TYR
SCHEMBL16055890 0.76 ERN1 (0.41) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL17440686 0.76 ERN1 (0.44) ERN1PRKDCALDH1A1TRIM24TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB ERN1 2714/4885PRKDC 3452/4885ALDH1A1 981/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB ERN1 2714/4885PRKDC 3452/4885ALDH1A1 981/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB ERN1 2714/4885PRKDC 3452/4885ALDH1A1 981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.